Created at 6:34 p.m. Jun, 13, 2025
Author:
rustinma
Type of change:
Updated content
Rationale for change
Reserpine is not really an option for us anymore. valbenazine still in clinical trials
Source: AMBOSS - https://next.amboss.com/us/article/AN0Rdg?q=valbenazine#Z0935f4e3cba47d0d2ab7c7ce011f6ee1
Current
Suggested
Extra
Extra
Extra
Extra
Text
Huntington disease may be treated with {{c1::tetrabenazine}} or {{c2::reserpine}}, which inhibit {{c3::VMAT-2}}, decreasing dopamine vesicle packaging and release
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy



Watch Indirect Sympathomimetics
Note: only reserpine is mentioned in the sketch, however, tetrabenazine also inhibits VMAT (both may be used to treat Huntington disease)



Watch Indirect Sympathomimetics
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Physeo
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
OME
Additional Resources
Empty field
One by one
Empty field
